T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
$1.87B |
| 2 |
T-Mobile US
TMUS
|
$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
$1.43B |
| 4 |
Apple
AAPL
|
$1.28B |
| 5 |
PepsiCo
PEP
|
$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$3.16B |
| 2 |
Amazon
AMZN
|
$3.02B |
| 3 |
GE Aerospace
GE
|
$2.2B |
| 4 |
Goldman Sachs
GS
|
$1.76B |
| 5 |
Salesforce
CRM
|
$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Biogen
BIIB
$20.6B
| $581M | 0.09% |
2,088,356
+691,843
| +50% | +$192M |
|
227
Endava
DAVA
$553M
| $577M | 0.09% |
8,588,111
+333,749
| +4% | +$22.4M |
|
228
Equity Lifestyle Properties
ELS
$12B
| $575M | 0.09% |
8,572,482
+837,152
| +11% | +$56.2M |
|
229
Mercado Libre
MELI
$123B
| $566M | 0.08% |
429,180
-45,675
| -10% | -$60.2M |
|
230
Tyson Foods
TSN
$20B
| $562M | 0.08% |
9,471,823
+4,669,457
| +97% | +$277M |
|
231
Rayonier
RYN
$4.12B
| $560M | 0.08% |
17,694,463
+339,190
| +2% | +$10.7M |
|
232
Globant
GLOB
$2.78B
| $559M | 0.08% |
3,406,155
+319,684
| +10% | +$52.4M |
|
233
Norfolk Southern
NSC
$62.3B
| $542M | 0.08% |
2,554,670
-170,151
| -6% | -$36.1M |
|
234
General Motors
GM
$55.5B
| $539M | 0.08% |
14,687,738
+6,548,022
| +80% | +$240M |
|
235
Select Medical
SEM
$1.62B
| $535M | 0.08% |
38,380,887
+114,878
| +0.3% | +$1.6M |
|
236
Schlumberger
SLB
$53.4B
| $527M | 0.08% |
10,736,684
+7,158,943
| +200% | +$352M |
|
237
Datadog
DDOG
$47.5B
| $522M | 0.08% |
7,181,438
-2,804,372
| -28% | -$204M |
|
238
Broadridge
BR
$29.4B
| $511M | 0.08% |
3,488,037
+96,566
| +3% | +$14.2M |
|
239
Charles River Laboratories
CRL
$8.07B
| $506M | 0.08% |
2,506,293
+653,790
| +35% | +$132M |
|
240
Apollo Global Management
APO
$75.3B
| $493M | 0.07% |
7,808,500
+827,935
| +12% | +$52.3M |
|
241
Centene
CNC
$14.2B
| $491M | 0.07% |
7,761,031
-15,608,916
| -67% | -$987M |
|
242
Bristol-Myers Squibb
BMY
$96B
| $486M | 0.07% |
7,007,819
-389,635
| -5% | -$27M |
|
243
RBC Bearings
RBC
$12.2B
| $483M | 0.07% |
2,075,761
-904,735
| -30% | -$211M |
|
244
KE Holdings
BEKE
$22.4B
| $483M | 0.07% |
25,623,503
-494,028
| -2% | -$9.31M |
|
245
State Street
STT
$32B
| $479M | 0.07% |
6,323,218
-1,326,118
| -17% | -$100M |
|
246
Align Technology
ALGN
$10.1B
| $472M | 0.07% |
1,413,060
-220,619
| -14% | -$73.7M |
|
247
RenaissanceRe
RNR
$11.3B
| $472M | 0.07% |
2,355,333
-749,959
| -24% | -$150M |
|
248
Sysco
SYY
$39.4B
| $471M | 0.07% |
6,098,467
-720,598
| -11% | -$55.7M |
|
249
Magna International
MGA
$12.9B
| $469M | 0.07% |
8,759,409
-7,482
| -0.1% | -$401K |
|
250
Teleflex
TFX
$5.78B
| $465M | 0.07% |
1,833,777
+612,019
| +50% | +$155M |
|